47 results
6-K/A
EX-99.3
KMDA
Kamada Ltd
17 Nov 22
Current report (foreign) (amended)
1:08pm
Revenue Service. Neither the Company nor any Affiliate thereof shall have any liability or responsibility relating to or arising out of the filing
6-K/A
EX-99.1
KMDA
Kamada Ltd
17 Nov 22
Current report (foreign) (amended)
1:08pm
of responsibility and authority of the Executive;
The obligations, responsibilities, roles and objectives imposed on the Executive under Applicable Law
6-K
EX-99.1
c8bn0glfbg0v
14 Mar 22
Kamada Expands U.S. Leadership Team with Two Key Appointments
7:01am
6-K
EX-99.2
2xf xsc1q3j
22 Nov 21
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
jocrp0l
29 Oct 20
Report of Foreign Private Issuer
5:00pm
6-K
EX-99.1
3k0w4bh1kqsf4i9xsws
12 Aug 20
Kamada Announces Changes to its Board of Directors
7:30am
6-K
EX-99.1
7bo473q0
27 Apr 20
Kamada and Kedrion Biopharma Announce Global Collaboration for the Development, Manufacturing and Polyclonal Immunoglobulin Product
7:00am
6-K
EX-99.1
yksly93x8jxco4xvzc
13 Feb 20
Report of Foreign Private Issuer
11:06am
6-K
EX-99.1
d1a02yqpfkxlm2
12 Nov 19
Current report (foreign)
7:30am